108 related articles for article (PubMed ID: 10023012)
21. Prognostic factors in the patients with T2N0M0 colorectal cancer.
Xu B; Yu L; Zhao LZ; Ma DW
World J Surg Oncol; 2016 Mar; 14():76. PubMed ID: 26965721
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; PĂ„hlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
24. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
25. Validation of a new classification system for curatively resected colorectal adenocarcinoma.
Sternberg A; Sibirsky O; Cohen D; Blumenson LE; Petrelli NJ
Cancer; 1999 Sep; 86(5):782-92. PubMed ID: 10463976
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in colorectal cancer.
Deans GT; Parks TG; Rowlands BJ; Spence RA
Br J Surg; 1992 Jul; 79(7):608-13. PubMed ID: 1643467
[TBL] [Abstract][Full Text] [Related]
27. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
28. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
[TBL] [Abstract][Full Text] [Related]
33. Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival.
Leen E; Angerson WG; Cooke TG; McArdle CS
Ann Surg; 1996 Feb; 223(2):199-203. PubMed ID: 8597515
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors affecting the survival of operated patients with colorectal cancer: significance of delayed hypersensitivity skin reactions and nutritional status.
Triantafillidis JK; Papatheodorou K; Kogevinas M; Manoussakis K; Nicolakis D
Ital J Gastroenterol; 1995; 27(8):419-24. PubMed ID: 8775467
[TBL] [Abstract][Full Text] [Related]
35. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
36. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
37. Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study.
Acciuffi S; Meyer F; Bauschke A; Settmacher U; Lippert H; Croner R; Altendorf-Hofmann A
J Cancer Res Clin Oncol; 2018 Mar; 144(3):593-599. PubMed ID: 29340767
[TBL] [Abstract][Full Text] [Related]
38. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study.
Cotte E; Peyrat P; Piaton E; Chapuis F; Rivoire M; Glehen O; Arvieux C; Mabrut JY; Chipponi J; Gilly FN;
Eur J Surg Oncol; 2013 Jul; 39(7):707-14. PubMed ID: 23601984
[TBL] [Abstract][Full Text] [Related]
39. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of argyrophil nucleolar organiser regions (AgNORs) in colorectal cancer.
Rayter Z; Surtees P; Tildsley G; Corbishley C
Eur J Surg Oncol; 1992 Feb; 18(1):37-40. PubMed ID: 1737591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]